Skip to main content

Advertisement

Log in

Clinical approach to renal study incidental to99mTc-MDP bone scintigraphy

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

In order to investigate the feasibility of the assessment of renal function with99mTc-MDP, we compared renographical images, renogram patterns and the glomerular filtration rate (GFR) obtained by means of a modified Gates’ method and 200 MBq of99mTc-MDP with those obtained by means of99mTc-DTPA. Because 19 of 20 patients had malignant tumors in the genitourinary tract, there was no difference between the two tracers in identifying a parenchymal defect corresponding to renal cancer. Of eight patients with hydronephrosis, four had a defect or decreased uptake with a dilated pelvis, whereas the other four had marked radioisotope retention in the renal pelvis or the whole kidney on serial images. There was also no difference between the two tracers in identifying hydronephrosis. Of 38 paired renograms 35 showed the same renogram patterns with both tracers. Of three patients with different renogram patterns, two had hydronephrosis. In 20 patients including three patients with bone metastasis, total GFR and split GFR obtained with both tracers correlated with a correlation coefficient of r=0.920 (p<0.001) and r=0.944 (p<0.001), respectively. Excluding bone metastasis from the analysis, a linear-regression analysis showed excellent agreement between the two measurements with a correlation coefficient of r=0.960 (p<0.001) and r=0.963 (p<0.001), respectively. The linear regression equations were Y=1.009X −0.111 and Y=1.034X−0.714, respectively. In conclusion,99mTc-MDP can be used as a supplement to evaluate renal function incidental to the survey of bone metastases in patients with malignant tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gates GF. Split renal function testing using99mTc-DTPA: a rapid technique for determining differential glomerular filtration.Clin Nucl Med 1983; 8: 400–407.

    Article  CAS  PubMed  Google Scholar 

  2. Taylor A. Radionuclide renography: a personal approach.Semin Nucl Med 1999; 29: 102–127.

    Article  CAS  PubMed  Google Scholar 

  3. Glass EC, DeNardo GL, Hines HH. Immediate renal imaging and renography with99mTc methylene diphosphonate to assess renal blood flow, excretory function, and anatomy.Radiology 1980; 135: 187–190.

    CAS  PubMed  Google Scholar 

  4. Adams KJ, Shuler SE, Witherspoon LR, Neely HR. A retrospective analysis of renal abnormalities detected on bone scans.Clin Nucl Med 1980; 5: 1–7.

    Article  CAS  PubMed  Google Scholar 

  5. Koizumi K, Tonami N, Hisada K. Diffusely increased Tc-99m-MDP uptake in both kidneys.Clin Nucl Med 1981; 6: 362–365.

    Article  CAS  PubMed  Google Scholar 

  6. Chayes ZW, Strashun AM. Improved renal screening on bone scans.Clin Nucl Med 1980; 5: 94–97.

    Article  CAS  PubMed  Google Scholar 

  7. Jacobson AF. Diffuse renal retention on bone scintigraphy in localized clear-cell renal epithelial neoplasm.J Nucl Med 1995; 36: 817–819.

    CAS  PubMed  Google Scholar 

  8. haden HT, Katz PG, Konerding KF. Detection of obstructive uropathy by bone scintigraphy.J Nucl Med 1988; 29: 1781–1785.

    CAS  PubMed  Google Scholar 

  9. Itoh K, Tsukamoto E, Nagao K, Nakada K, Kanegae K, Furudate M. Captopril renography with Tc-99m DTPA in patients with suspected renovascular hypertension prospective and retrospective evaluation.Clin Nucl Med 1993; 18: 463–471.

    Article  CAS  PubMed  Google Scholar 

  10. Bilchik TR, Spencer RP. Bladder variants noted on bone and renal imaging.Clin Nucl Med 1993; 18: 60–67.

    Article  CAS  PubMed  Google Scholar 

  11. Zuckier LS, Weissmann HS, Kaplun L, Schlossberg I, Gade MF, Freeman LM. Significance of skeletal uptake detected on radionuclide renal perfusion studies.Clin Nucl Med 1987; 12: 448–452.

    Article  CAS  PubMed  Google Scholar 

  12. Vieras F, Achong DM, Tulchinsky M, Smith JJ. Quantitation of differential renal function with Tc-99m MDP.Clin Nucl Med 1991; 16: 649–651.

    Article  CAS  PubMed  Google Scholar 

  13. Yamashita M, Miyazaki T, Imahori Y, Ohmori Y, Oka T, Murakami K. Renogram study using99mTc-methylenediphosphonate.Radioisotopes 1985; 34: 382–385.

    CAS  PubMed  Google Scholar 

  14. Russell CD, Bischoff PG, Konzen F, Rowell KL, Yester MV, Lloyd LK, et al. Measurement of glomerular filtration rate using99mTc-DTPA and the gamma camera: a comparison of methods.Eur J Nucl Med 1985; 10: 519–521.

    Article  CAS  PubMed  Google Scholar 

  15. Awdeh M, Kouris K, Hassan IM, Abdel Dayem HM. Factors affecting the Gates’ measurement of glomerular filtration rate.Am J Physiol Imag 1990; 5: 36–41.

    CAS  Google Scholar 

  16. Siddiqui AR. Increased uptake of technetium-99m-labeled bone imaging agents in kidneys.Semin Nucl Med 1982; 12: 101–102.

    Article  CAS  PubMed  Google Scholar 

  17. Lutrin CL, McDougall IR, Goris ML. Intense concentration of Tc-99m-pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease.Radiology 1978; 128: 165–167.

    CAS  PubMed  Google Scholar 

  18. Arbona GL, Antonmattei S, Tetalman MR, Scheu JD. Tc-99m-diphosphonate distribution in a patient with hypercalcemia and metastatic calcifications.Clin Nucl Med 1980; 5: 422.

    Article  CAS  PubMed  Google Scholar 

  19. Sheth KJ, Sty JR, Johnson F, Tisdale P. Myoglobinuria with acute renal failure and hot kidneys seen on bone imaging.Clin Nucl Med 1984; 9: 498–501.

    Article  CAS  PubMed  Google Scholar 

  20. Lantieri RL, Lin MS, Martin W, Goodwin DA. Increased renal accumulation of Tc-99m-MDP in renal artery stenosis.Clin Nucl Med 1980; 5: 305–309.

    Article  CAS  PubMed  Google Scholar 

  21. Lamki LM, Wyatt JK. Renal vein thrombosis as a cause of excess renal accumulation of bone seeking agents.Clin Nucl Med 1983; 8: 267–268.

    Article  CAS  PubMed  Google Scholar 

  22. Titelbaum DS, Fowble BF, Powe JF, Martinez FJ. Renal uptake of technetium-99m methylene diphosphonate following therapeutic radiation for vertebral metastases.J Nucl Med 1989; 30: 1113–1116.

    CAS  PubMed  Google Scholar 

  23. Choy D, Murray PC, Hoschl R. The effect of iron on the biodistribution of bone scanning agents in humans.Radiology 1981; 140: 197–202.

    CAS  PubMed  Google Scholar 

  24. Watanabe N, Shimizu M, Kageyama M, Kamei T, Seto H, Kakishita M. Diffuse increased renal uptake on bone scintigraphy in acute renal tubular necrosis.Clin Nucl Med 1993; 19: 19–21.

    Article  Google Scholar 

  25. Challa S, Miller JF. Extraskeletal uptake of technetium-99m-MDP in sites of heparin administration.J Nucl Med 1998; 39: 893–895.

    CAS  PubMed  Google Scholar 

  26. Bernard MS, Hayward M, Hayward C, Mundy L. Evaluation of intense renal parenchymal activity (“hot kidneys”) on bone scintigraphy.Clin Nucl Med 1990; 15: 254–256.

    Article  CAS  PubMed  Google Scholar 

  27. Taylor A, Corrigan P, Galt J, Garcia EV, Forks R, Jones M, et al. Measuring Tc-99m MAG3 clearance with an improved camera based method.J Nucl Med 1995; 36: 1689–1695.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Teruhiko Takayama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takayama, T., Kinuya, S., Kobashi, K. et al. Clinical approach to renal study incidental to99mTc-MDP bone scintigraphy. Ann Nucl Med 15, 237–245 (2001). https://doi.org/10.1007/BF02987838

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02987838

Key words

Navigation